Towards open science : promoting innovation in pharmaceutical research and development and access to affordable medications both in Canada and abroad / Bill Casey, chair.: XC62-1/1-421-20E-PDF
"In Canada and around the world, there is rising concern that innovative drugs produced by pharmaceutical companies are no longer affordable and are placing increasing strain on health care budgets. Policy makers have begun to examine ways that public funding for pharmaceutical research and development could address this issue"--Summary, page 1.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.865221&sl=0
| Department/Agency | Canada. Parliament. House of Commons. Standing Committee on Health. |
|---|---|
| Title | Towards open science : promoting innovation in pharmaceutical research and development and access to affordable medications both in Canada and abroad / Bill Casey, chair. |
| Variant title | Promoting innovation in pharmaceutical research and development and access to affordable medications both in Canada and abroad |
| Series title | Report of the Standing Committee on Health ; 20th report, 42nd Parliament, 1st session |
| Publication type | Series - View Master Record |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | "November 2018." Issued also in HTML format. Original published on: 2018/11/26; published on: 2018/11/28; published on: 2019/05/09. Issued also in French under title: Vers la science ouverte : promouvoir l'innovation en recherche et en développement pharmaceutique, et l'accès à des médicaments abordables au Canada et à l'étranger. Includes bibliographical references. |
| Publishing information | [Ottawa] : House of Commons, 2018. |
| Author / Contributor | Casey, Bill, 1945- |
| Description | 1 online resource (viii, 27 pages) : graphs. |
| Catalogue number |
|
| Subject terms | Pharmaceutical industry Research and development Drugs |